ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 86 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $50,000 | -67.3% | 13,023 | -42.8% | 0.00% | -60.0% |
| Q4 2014 | $153,000 | +159.3% | 22,781 | +112.4% | 0.01% | +150.0% |
| Q3 2014 | $59,000 | -62.2% | 10,723 | -29.4% | 0.00% | -50.0% |
| Q2 2014 | $156,000 | +5.4% | 15,193 | +16.4% | 0.00% | 0.0% |
| Q4 2013 | $148,000 | -8.6% | 13,052 | -13.2% | 0.00% | -20.0% |
| Q3 2013 | $162,000 | – | 15,035 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |